Introduction
============

Autism spectrum disorders (ASDs) refer to a group of pervasive developmental disorders caused by a combination of genetic and environmental factors. They are often associated with pronounced personal suffering and heavy burden of care to families and society [@B1]. ASDs consist of several subtypes, with autism being the core and the most common one. ASDs usually occur in infancy [@B2] and present with complex symptoms. Children with ASDs usually have difficulties in understanding language and social behaviors; parental concern is often centered around their children presenting abnormal behaviors, such as mutism, echolalia and lack of expressive emotion [@B3].

Accurate estimation of the prevalence of ASDs is important for the health sectors to understand its impact on the general population and provide appropriate resource allocations. A number of epidemiological studies have found an increasing trend in prevalence of ASDs, for example, in the 1990s the prevalence rate of ASDs were 4-5 per 10,000 in the USA, as compared to 113 per 10,000 in 2008 [@B4]. The apparent growing trend could be partly explained by the discrepancy in age of subjects, diagnostic criteria and sampling methods [@B5]. In addition, there is wide variation in the prevalence of ASDs between countries. For instance, the prevalence of autism was 34 per 10,000 in USA [@B6] versus 99 per 10,000 in the UK [@B7]. A review of 23 studies found that the estimated prevalence of ASDs across Asia countries/ territories (China, Japan, Israel, Iran, Taiwan and Indonesia) varied from 1.1 to 21.8 per 10,000 [@B8].

In China, prevalence studies of ASDs have shown conflicting findings. Moreover, most studies were published in Chinese-language journals that are not accessible to international readership. A review of 24 studies [@B9] found that the pooled prevalence of ASDs in Chinese children was 24.5 per 10,000. Another meta-analysis of 18 studies in China [@B10] found that a pooled prevalence of autism of 11.8 per 10,000. More than 20 ASDs prevalence studies have been recently published in Chinese, which have enhanced the epidemiological dataset, but are generally not accessible to the international readership. Therefore, we set out to conduct this comprehensive meta-analysis of the pooled prevalence of ASDs in China and also to examine its mediating factors (e.g., gender, region, study period, and diagnostic tools used).

Methods
=======

Search strategy and selection criteria
--------------------------------------

The literature search process is shown in Figure [1](#F1){ref-type="fig"}. Two investigators (WF and LL) independently searched the literature using PubMed, EMBASE, PsycINFO, China National Knowledge Infrastructure, Chinese biomedical literature service system (SinoMed) and Wan Fang, from their inception to February 1^st^ 2017. Search terms included (\'autism\' or \'autistic disorder\' or \'autism spectrum conditions\' or \'pervasive developmental disorders\' or \'Asperger\') and (\'epidemiology\' or \'cross-sectional study\' or \'prevalence\' or \'rate\') and (\'China\' or \'Chinese\'). In order to avoid missing any studies, the reference lists of relevant review or meta-analyses were searched manually. If more than one publication was reported based on the same dataset, only the paper with complete data was included.

Inclusion criteria were as follows: 1) cross-sectional or cohort studies conducted in mainland China (China thereafter) (only baseline data were extracted in the latter); 2) participants aged ≤18 years; 3) the diagnosis of ASD was established by either clinical diagnostic criteria \[such as the Diagnostic and Statistical Manual of Mental Disorder (DSM), Chinese Classification of Mental Disorder (CCMD) or International Classification of Disease (ICD) systems\], or screening tools \[such as the Clancy Autism Behavior Scale (CABS), Children Autism Spectrum Test (CAST) and Checklist for Autism in Toddlers (CHAT)\]. Both clinical diagnostic criteria and screening tools on ASDs and autism were involved because they have been widely used in epidemiology and clinical practice in China.

Studies selection and data extraction
-------------------------------------

After removing the duplicates, two investigators (WF and LL) independently screened the titles and abstracts of all records, and then selected the articles that fulfilled the inclusion criteria. Any uncertainties were resolved by consensus or with a third reviewer (WSB).

The same two investigators independently performed the data extraction using a standard data extraction form. Information extracted included the study characteristics (e.g., title, the first author, publication year, study site, survey time, sample method, sample size, response rate), ASD subtype, age, gender proportion, residence (urban/ rural area), screening and diagnostic tools, and data on the prevalence of ASDs and subtypes.

Quality assessment
------------------

Two investigators (WF and LL) independently assessed the quality of included studies using a methodological quality assessment tool with 8 items [@B11], [@B12]. Each study was scored from 0 to 8. The score of 7-8 indicated \'high quality\', 4-6 indicated \'moderated quality\' and 0-3 indicated \'low quality\' [@B12]. Any disagreement in the assessment process was discussed and resolved with a third investigator (WSB).

Statistical analysis
--------------------

The Comprehensive Meta-Analysis software version 2 was used to synthesize the data. Due to the heterogeneity in sampling methods, assessment instruments and sample size across studies, random-effects model was used to estimate the pooled prevalence of ASD [@B13]. The I^2^ statistic was used to assess the degree of heterogeneity across included studies. Sensitivity and subgroup analysis were used to examine the sources of heterogeneity if present. Publication bias was evaluated with the funnel plots and Egger\'s test and the significance level was set at 0.05 (two-sided).

Results
=======

Search results and characteristics of studies
---------------------------------------------

Of 2,375 eligible papers identified in literature search, 44 fulfilled the inclusion criteria after screening the titles, abstracts and full texts, and removing the duplicates (Figure [1](#F1){ref-type="fig"}). Five of these studies were published in English and thirty-nine in Chinese. Their sample size ranged from 259 to 1,348,030 subjects and 42 studies had a sample size greater than 1000. The 44 included studies had a total of 2,337,321 subjects of which 46.66% were females. Sixteen studies reported on the prevalence of ASDs, while 28 focused on the prevalence of autism.

The characteristics of the included studies are shown in Table [1](#T1){ref-type="table"}. These studies were conducted between 2000 and 2016 in 30 provinces/ municipalities/ autonomous regions in China. Mean age of the subjects ranged from 1.6 to 8 years, with the median age of 4 years. Twenty-seven studies were conducted in urban areas (61.4%) and the others were in both urban and rural areas (urban/rural were defined by the studies included in the meta-analysis). Twenty-seven studies were conducted in eastern China, nine in central China, seven studies in western China, and one study was a national survey. The CABS was the most commonly used screening tool (22/44).

Evaluation quality of the studies
---------------------------------

The quality assessment scores ranged from 4 to 8. Based on the assessment criteria, 7 studies were rated as \'high quality\', and 37 was as \'moderate quality\' (Table [4](#T4){ref-type="table"}).

Prevalence of ASDs
------------------

### Prevalence of ASDs based on clinical diagnostic criteria

The pooled prevalence of ASDs from 16 studies with available data was 39.23 per 10,000 (95% CI: 28.44 to 50.03 per 10,000, I^2^=89.2%) (Figure [2](#F2){ref-type="fig"}A). The prevalence of ASDs in males (72.77 per 10,000) was higher than in females (16.45 per 10,000). The prevalence of ASDs in rural areas was higher than in urban areas (62.26 per 10,000 vs. 32.73 per 10,000). The pooled prevalence of ASDs from studies conducted in or before 2012 was slightly higher than that those after 2012 (38.72 per 10,000 vs. 36.36 per 10,000) after study years were dichotomized using median splitting method. The prevalence of ASDs in eastern and central China was 45.81 per 10,000 and 50.85 per 10,000, respectively. Meta-regression analysis did not find any association between age and prevalence of ASDs (p=0.784). Subgroup analyses of diagnostic instruments used revealed no difference between prevalence of ASDs established by CCMD (63.75 per 10,000), DSM-4 (41.87 per 10,000) or DSM-5 (48.96 per 10,000). However, one prevalence study using the Autism Diagnostic Observation Schedule (ADOS) (85.59 per 10,000) showed a higher figure than others (Table [2](#T2){ref-type="table"}).

### Prevalence of ASDs based on screening tools

The pooled prevalence of ASDs from 11 studies with available data was 429.07 per 10,000 (95% CI: 324.45 to 533.69 per 10,000, I^2^=99.5%) (Figure [3](#F3){ref-type="fig"}A). The prevalence of ASDs in males (503.53 per 10,000) was slightly higher than in females (294.22 per 10,000). Prevalence of ASDs in rural and urban was 50.03 per 10,000 and 141.74 per 10,000, respectively. Median splitting method was used to dichotomize continuous variables in subgroup analysis. Prevalence of ASDs from studies conducted in and before 2012 was 1149.51 per 10,000, while those done after 2012 was 188.30 per 10000. The prevalence of ASDs in eastern China (494.32 per 10,000) was higher than central China (290.11 per 10,000), while no data was available in western China. Age was collapsed into two groups (≤4 years; \>4 years) using median splitting method. The prevalence of ASDs in children aged ≤4 years were higher than in children \> 4 years (530 per 10,000 vs. 80 per 10,000). Eleven studies using the CABS, CAST, and CHAT, respectively provided different screening rates (422.06 per 10,000 vs. 499.29 per 10,000 vs. 431.86 per 10,000) (Table [3](#T3){ref-type="table"}).

### Prevalence of autism

#### Prevalence of autism based on clinical diagnostic criteria

The pooled prevalence of autism from 25 studies with available data was 10.18 per 10,000 (95% CI: 8.46-11.89 per 10,000, I^2^=92.5%) (Figure [2](#F2){ref-type="fig"}b). The prevalence of autism in males (20.50 per 10,000) was higher than in females (6.12 per 10,000). The prevalence of autism in urban areas was around 2 folds higher than in rural areas (14.80 per 10,000 vs. 6.06 per 10,000). The prevalence of autism from studies conducted after 2008 was higher than those in or before 2008 (20.40 per 10,000 vs. 8.18 per 10,000). The prevalence of autism between the eastern, western and central China showed some variation (14.62 per 10,000 vs. 6.41 per 10,000 vs. 8.68 per 10,000). The prevalence of autism in the group of children aged ≤2.08 years (40 per 10,000) was significantly higher than those aged \>2.08 years (20 per 10,000). With the exception of one study reporting a low prevalence (2.96 per 10,000) using the DSM-3, there was no difference in prevalence of autism between other diagnostic criteria (14.78 per 10,000 using ABC, 10.05 per 10,000 using CCMD, 17.03 per 10,000 using DSM-4, and 10.14 per 10,000 using ICD-10) (Table [2](#T2){ref-type="table"}).

#### Prevalence of autism based on screening tools

The pooled prevalence of autism from 22 studies with available data was 252.84 per 10,000 (95% CI: 216.1-289.57 per 10,000, I^2^=99.5%) (Figure [3](#F3){ref-type="fig"}B). The prevalence of autism in males (377.25 per 10,000) was higher than in females (247.89 per 10,000). The prevalence of autism from studies conducted in and before 2006 was 39.17 per 10,000, while those done after 2006 had increased to 349.82 per 1000. The prevalence of autism in central China (334.73 per 10,000) was higher than eastern China (260.11 per 10,000) and western China (149.78 per 10,000). The prevalence of autism was different between the two age groups (290 per 10,000 in those aged ≤3.58 years; 440 per 10,000 aged \> 3.58 years)*.* Significant difference in the prevalence of autism between different screening tools was observed (136.67 per 10,000 using ABC; 268.94 per 10,000 using CABS; 406.73 per 10,000 using CHAT) (Table [3](#T3){ref-type="table"}).

Sensitivity analysis and publication bias
-----------------------------------------

The sensitivity analyses did not find any individual studies that significantly influence the overall results in each diagnostic group. Egger\'s test revealed publication bias for ASDs (ASDs: t=2.33, P=0.036), but not for autism (t=1.506, P=0.143).

Discussion
==========

This comprehensive meta-analysis of the pooled prevalence of ASDs and autism included 44 studies with 2,337,321 subjects in China covering 30 of the 34 provinces/ municipalities/ autonomous regions of the country. The large variation in prevalence between studies is probably due to methodological differences in sampling methods and screening tools or diagnosis criteria used. This meta-analysis found that the pooled prevalence of ASD based on clinical diagnostic criteria was 39.23 per 10,000, which is lower than in other countries worldwide. For example, Duchan et al. [@B14] found that the prevalence of ASDs was 60 per 10,000 in North America. In Europe, the median rate of ASD was 61.9 per 10,000 [@B15], while in the USA the prevalence of ASD was 110 per 10,000 [@B16]. Further, in Asia the figure was 264 per 10,000 in South Korea [@B17] and 181 per 10,000 in Japan [@B18].

On the other hand, the pooled prevalence of autism of 10.18 per 10,000 established by clinical diagnostic criteria was similar to the systemic review of 24 studies in China (12.8 per 10,000) [@B9] and another meta-analysis of 18 studies (11.8 per 10,000) [@B10]. Although significant heterogeneity between studies (I^2^=92.5%) was noted, sensitivity analyses did not find any outlying studies that significantly affect the overall results in each diagnostic group.

Screening tools on ASDs and autism have been widely used in epidemiological surveys globally. Based on such screening tools, in this study the prevalence of ASDs ranged from 33 per 10,000 to 1853.3 per 10,000 with the pooled figure of 429.07 per 10,000, while the prevalence of autism ranged from 10 per 10,000 to 1259.8 per 10,000 with the pooled figure of 252.84 per 10,000. The CABS was the most commonly used screening tool for autism in China [@B19], but rarely used in Western studies. In contrast, the ADOS and Autism Diagnostic Interview- Revised (ADI-R) were widely used in Western studies. In addition, the ADOS and ADI-R included more information than the CABS. Thus, the discrepancy in screening tools used for ASDs and autism could partly explain the different findings between Chinese and Western studies [@B10].

Previous studies found that the prevalence of ASD and autism established by clinical diagnostic criteria in males was 3-4 times higher than in females [@B20], [@B21], which is consistent with the results of our study. We also found that the pooled prevalence of autism in urban areas was significantly higher than in rural areas, which is concordant with the urban/rural rates in other developed countries, such as in the USA [@B22]. Various environmental stressors [@B23], such as prenatal exposure to environmental stress [@B24] and lower parental education [@B16] may partly lead to the urban/ rural difference. However, the urban /rural difference was not found in the prevalence of ASDs in this study.

Children aged 2-6 years had the highest prevalence of ASDs in previous surveys. This study found that the age group ≤4 years had a higher prevalence (530 per 10,000) than the group \> 4 years (80 per 10,000), which is not consistent with the findings (the highest risk in children aged 4-6 years) in a national survey in China [@B25]. In China children with ASDs are usually sent to special schools, which may result in an underestimated prevalence of ASDs in school age children in epidemiological surveys. Further, screening tools that have been widely used in China, such as the CABS, were originally designed to be completed by parents [@B26]. Parents may wish to avoid the diagnosis of autism or hoped that the symptoms would be reversed in their children, which may lead to an underestimation in self-reported surveys [@B7]. All these factors could contribute to the relatively lower prevalence of ASDs in school age groups [@B27].

The prevalence of autism based on clinical diagnostic criteria in studies done before the year 2008 (8.18 per 10,000) was significantly lower than that after 2008 (20.4 per 10,000), which was consistent with previous findings [@B14]. However, the trend appeared to be the opposite in the prevalence of ASDs (38.72 per 10,000 in and before 2012, and 36.36 per 10,000 after 2012). The discrepancy in findings across study period may be related to differences in diagnostic criteria and qualification of interviewers. In addition, children with ASDs usually present with complex symptoms, which could lead to inaccurate diagnosis [@B28]. The improvement of standardized interview and diagnostic instruments could partly explain the increased prevalence of autism over time.

The results need to be interpreted with caution due to several limitations. First, heterogeneity was present even in subgroup analyses although such heterogeneity is difficult to avoid in epidemiological studies [@B29]. Second, different screening instruments and diagnostic criteria were used across studies. In order to reduce the relevant heterogeneity, subgroup analyses between different screening instruments and diagnostic criteria were conducted. Third, the 44 studies in this meta-analysis covered 30, but not all the 34 provinces/municipalities/autonomous regions in China. Finally, relevant factors on the prevalence of ASDs, such as socioeconomic and environmental variables, were not recorded in the majority of papers, therefore their impact could not be examined.

In conclusion, the prevalence estimates of ASDs and autism are generally lower in China than in other countries worldwide. Further epidemiological studies with stringent methodology are needed to clarify the variation in prevalence.
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###### 

Quality assessment of the included studies

  Items                                                                                                                                                  Yes, n (%)   No, n (%)   Unclear, n (%)
  ------------------------------------------------------------------------------------------------------------------------------------------------------ ------------ ----------- ----------------
  1\. Is the target population clearly defined?                                                                                                          43 (97.7)    1 (2.27)    0
  2\. Was either of the following ascertainment methods used \[must be one or the other\]? (1) probability sampling, or (2) entire population surveyed   41 (93.2)    3 (6.82)    0
  3\. Is the response rate \>70%                                                                                                                         26 (59.1)    18 (40.9)   0
  4\. Are nonresponders clearly described?                                                                                                               2 (4.5)      42 (95.5)   0
  5\. Is the sample representative of the target population?                                                                                             42 (95.5)    2 (4.5)     0
  6\. Were data collection methods standardized?                                                                                                         44 (100)     0           0
  7\. Were validated criteria used to assess for the presence/absence of disease?                                                                        44 (100)     0           0
  8\. Are the estimates of prevalence given with confidence intervals and in detail by subgroup (if applicable)?                                         9 (20.5)     35 (79.5)   0

###### 

Characteristic of the included studies

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study\   First Author   Ref      Region        Sample\   Area\*\          Age (years)    Sample   Sampling\   Screening/ diagnostic tools          Diagnostic\       Autism events according to diagnostic criteria   ASD events according to diagnostic criteria
  year                                           Size      (urban/ rural)                           methods                                          criteria                                                           
  -------- -------------- -------- ------------- --------- ---------------- -------------- -------- ----------- ------------------------------------ ----------------- ------------------------------------------------ ---------------------------------------------
  1996     Luo            [@B30]   Fujian        10802     Mixed            0 to 14        G        CL          ABC                                  CCMD-2-R; DSM 3   3                                                ------

  1999     Jiang          [@B31]   Luoyang       10140     Mixed            NA to NA       PS,K     R           ------                               DSM 3             3                                                ------

  2000     Ren            [@B32]   Tongling      3559      Urban            3 to 5         K        CL          CABS                                 ------            ------                                           ------

  2001     Zhang          [@B33]   Guiyang       4999      Urban            0 to 6         G        S; CL       CABS; CARS                           CCMD              5                                                ------

  2001     Guo            [@B34]   Tianjin       5000      Urban            0 to 6         G        R           CABS; CARS; PEP                      CCMD              5                                                ------

  2001     Wang           [@B35]   Changzhou     7344      Mixed            NA to NA       G        S; CL       CABS                                 CCMD              9                                                ------

  2003     Yang           [@B36]   Zunyi         10412     Urban            NA to NA       PS       R           ABC                                  DSM 4             6                                                ------

  2003     Liu            [@B37]   Beijing       21866     Mixed            2 to 6         G        S; CL       CABS; CARS                           DSM 4             14                                               ------

  2003     Guo            [@B38]   Dingxi        3770      Mixed            2 to 6         G        R           CABS; CARS                           DSM 4             3                                                ------

  2004     Zhang          [@B39]   Tianjin       7345      Urban            2 to 6         G        R           CABS                                 DSM 4             8                                                ------

  2006     Ji             [@B40]   Nationwide    585679    Both             2 to 17        G        R           Disability screening questionnaire   ICD10             124                                              ------

  2007     Su             [@B41]   Tianjin       7904      Urban            1.5 to 3       REG      S; CL       CHAT; CARS                           DSM 4             22                                               ------

  2007     Zhang          [@B42]   Wuxi          25521     Urban            1 to 6         C        CL          CHAT;CABS; CARS                      DSM 4             25                                               ------

  2008     Wang           [@B43]   Meizhou       4156      Urban            2 to 6         K        CL          CABS                                 ------            ------                                           ------

  2009     Pu             [@B44]   Guizhou       3211      Urban            2 to 6         K        CL          CABS                                 DSM 4             7                                                ------

  2009     Huang          [@B45]   Tianjin       8000      Urban            1.5 to 3       G        M           CHAT                                 DSM 4             ------                                           22

  2009     Zhou           [@B46]   Shenzhen      2960      Urban            1 to 2         G        R           CHAT                                 ------            9                                                ------

  2009     Wu             [@B47]   Lianyungang   8532      Urban            0 to 3         C        R           CHAT; CARS                           DSM 4             9                                                ------

  2009     Chen           [@B48]   Daqing        7034      Mixed            2 to 6         K, G     S; CL       CABS; ABC                            DSM4              ------                                           17

  2009     Liang          [@B49]   Maoming       2485      Urban            3 to 6         K        CL          CABS                                 ICD10; DSM 4      35                                               ------

  2009     Liu            [@B50]   Shanghai      259       Urban            1.5 to 2       K        CL          CHAT                                 DSM 4             1                                                2

  2009     Wang           [@B51]   Guizhou       6111      Urban            2 to 6         K        M           CABS; CARS                           DSM 4             ------                                           46

  2009     Yu             [@B52]   Haerbin       7059      Mixed            2 to 6         K        S; CL       CABS;ABC                             DSM 4             15                                               16

  2009     Li             [@B53]   Tianjin       8274      Urban            1.5 to 3       REG      S; CL       CHAT; CARS                           DSM4              22                                               ------

  2011     Li             [@B54]   Guiyang       1550      Urban            1.5 to 3       C        CL          M-CHAT; ABC                          DSM 4             48                                               ------

  2011     Wei            [@B55]   Shenzhen      3624      Urban            1.5 to 2       C        CL          CHAT; CARS                           DSM4              7                                                10

  2012     Wang           [@B56]   Lianyungang   2090      Both             1.5 to 3       C        S; CL       CABS                                 DSM-V             ------                                           24

  2012     Li             [@B57]   Changchun     9714      Urban            0 to 6         G        R           ABC; CARS                            CCMD3             15                                               ------

  2012     Chen           [@B58]   Zhuhai        4754      Both             1.5 to 3       REG      R           CHAT; CARS                           DSM4              ------                                           14

  2012     Yang           [@B59]   Wuhan         8695      Urban            3 to 7         K        CL          CABS                                 ------            ------                                           ------

  2012     Duan           [@B60]   Zhengzhou     1000      NA               1.5 to 3       C        CL          CHAT; CARS; ABC                      DSM 4             ------                                           9

  2012     Wu             [@B61]   Ningxia       1348030   NA               0 to 14        REG      CL          ABC; CARS                            ICD-10            419                                              ------

  2013     Li             [@B62]   Shenzhen      1845      Urban            1.5 to 2       C        CL          CABS                                 DSM-IV            4                                                ------

  2013     Wang           [@B63]   Shantou       51968     Urban            3 to 6         REG      R           CABS                                 ICD 10            139                                              ------

  2013     Gao            [@B64]   Zhongshan     12804     Both             3 to 6         K        S; CL       CABS                                 ------            ------                                           ------

  2013     Deng           [@B65]   Hengyang      7041      Both             2 to 6         K        CL          CABS; CARS                           DSM 4             16                                               42

  2014     Wang           [@B66]   Jiangmen      65651     Both             2 to 7         K        CL          CABS; ABC                            ABC               97                                               ------

  2014     Wang           [@B67]   Zaozhuang     6634      NA               2 to 6         K        S; CL       CABS                                 DSM-5             ------                                           44

  2014     Yang           [@B68]   Shenzhen      15188     Urban            3.83 to 4.83   K        CL          ABC                                  ------            ------                                           ------

  2014     Jiang          [@B69]   Shanghai      9665      Urban            4 to 6         K        CL          CABS;ASSQ                            ADI-R;DSM-5       9                                                9

  2014     Sun            [@B70]   Beijing       701       Urban            6 to 11        PS       CL          CAST                                 ADOS;ADIR         ------                                           ------

  2014     Lu             [@B71]   Shanghai      5704      Urban            2 to 6         K        CL          CABS                                 DSM-5             ------                                           6

  2014     Cheng          [@B72]   Ningbo        12123     Both             1 to 6         C        S; CL       CHAT; ABC                            DSM-IV-TR         ------                                           14

  2015     Tian           [@B73]   Jilin         6118      Urban            6 to 11        PS       CL          CAST                                 CCMD              ------                                           39
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\* Rural/urban areas were defined by included studies. Sample screen: C, clinical service; G, general population; K, kindergarten; PS, population sample; REG, registration data; Sample method: CL, cluster; M, multiphase; R, random; S, stratified Screen tools: ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in Toddlers; M-CHAT, Modified Checklist for Autism in Toddlers; CAST, Children Autism Spectrum Test; ASSQ, high function Autism Spectrum screening questionnaire; PEP, Childhood Autism And Developmental Disabilities Psychological Assessment Scale (Psycho-educational Profile, PEP); Diagnostic criteria: ADI-R, Autism Diagnostic Interview-Revised; CCMD-2-R, Chinese Classification of Mental Disorders, 2nd edition, revised; DSM-III-R, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition; ICD-10, International Classification of Diseases, 10th revision; ASC, autism spectrum conditions;

###### 

Subgroup analyses of prevalence of ASD and autism based on clinical diagnostic criteria

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                        Number of studies   N        Event    I^2^ (%)   P         Prevalence\   95% CI (per 10000)\   95% CI (per 10000)\   u-value   P
                                                                                                   (per 10000)   Lower                 Upper                           
  --------------------- --------------- ------------------- -------- -------- ---------- --------- ------------- --------------------- --------------------- --------- ---------
  **ASDs**              16              87917               320      89.29    \<0.001    39.23     28.44         50.03                 1457.90                         

  Gender                Male            13                  41155    253      98.77      \<0.001   72.77         54.16                 91.39                 30.343    \<0.001

  Female                13              36137               50       93.98    \<0.001    16.45     11.85         21.06                                                 

  Area                  Urban           6                   35744    88       91.27      \<0.001   32.73         20.52                 44.95                 0.216     0.642

  Rural                 2               8384                26       96.5     \<0.001    62.26     37.29         161.80                                                

  Study time            2009-2012       9                   44882    178      98.55      \<0.001   38.72         26.49                 50.94                 0.689     0.406

  \>2012                7               43035               136      99.24    \<0.001    36.36     19.75         52.98                                                 

  Study site            East of China   11                  59665    191      99.16      \<0.001   45.81         34.05                 57.58                 0.392     0.531

  West of China         \-\--           \-\--               \-\--    \-\--    \-\--      \-\--     \-\--         \-\--                                                 

  Central China         5               28252               123      98.51    \<0.001    50.85     31.69         70.02                                                 

  Diagnostic criteria   ADOS            1                   701      6        \-         \-        85.59         64.88                 106.30                1.924     0.588

  CCMD                  1               6118                39       \-       \-         63.75     57.63         69.87                                                 

  DSM-4                 10              57005               192      98.74    \<0.001    41.87     30.26         53.47                                                 

  DSM-5                 4               24093               83       99.52    \<0.001    48.96     24.99         72.93                                                 

                                                                                                                                                                       

  **Autism**            25              2218950             987      99.975   \<0.001    10.18     8.46          11.89                 97232.57                        

  Gender                Male            14                  423777   360      99.69      \<0.001   20.50         12.98                 28.02                 8.679     0.003

  Female                14              370495              119      98.80    \<0.001    6.12      3.08          9.16                                                  

  Area                  Urban           20                  304580   434      96.36      \<0.001   14.80         9.87                  19.72                 4.105     0.043

  Rural                 5               506027              147      95.45    \<0.001    6.06      1.13          11.00                                                 

  Study time            1996-2008       8                   657661   199      99.60      \<0.001   8.18          4.36                  12.00                 5.113     0.024

  2009-2013             8               85530               200      94.05    \<0.001    20.40     14.05         26.74                                                 

  Study site            East of China   14                  227497   401      99.38      \<0.001   14.62         9.86                  19.38                 0.556     0.757

  West of China         6               1371972             488      99.94    \<0.001    6.41      2.41          10.40                                                 

  Central China         2               19854               18       98.55    \<0.001    8.68      3.51          20.87                                                 

  Diagnostic criteria   ABC             1                   65651    97       \-         \-        14.78         13.85                 15.70                 4.149     0.386

  CCMD                  5               37859               37       94.77    \<0.001    10.05     4.52          15.57                                                 

  DSM-III               1               10140               3        \-       \-         2.96      1.90          4.02                                                  

  DSM-IV                13              108131              150      97.33    \<0.001    17.03     13.09         20.97                                                 

  ICD-10                4               1994209             691      99.95    \<0.001    10.14     8.10          12.19                                                 

  Age (years)           ≤2.08           5                   15552    82       96.92      \<0.001   40            10                    140                   0.976     0.323

  \>2.08                4               40208               128      8.861    \<0.001    20        10            70                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Diagnosis tools: ABC, Autism Behavior Checklist; ADOS: Autism Diagnostic Observation Schedule; CCMD, Chinese Classification of Mental Disorders; DSM-III, Diagnostic and Statistical Manual of Mental Disorders, 3rd edition, revised; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, 4th edition; DSM-V, Diagnostic and Statistical Manual of Mental Disorders, 5th edition; ICD-10, International Classification of Diseases, 10th revision

###### 

Subgroup analyses of prevalence of ASD and autism based on screening tools

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                    Number of studies   N        Event   I^2^(%)   P         Prevalence\   95% CI\              95% CI\              u-value   p
                                                                                             (per 10000)   (per 10000); Lower   (per 10000); Upper             
  ----------------- --------------- ------------------- -------- ------- --------- --------- ------------- -------------------- -------------------- --------- ---------
  **ASD**           11              67321               2203     99.43   \<0.001   429.07    324.45        533.69               1765.58                        

  Gender            Males           4                   12223    287     99.09     \<0.001   503.53        247.72               759.35               0.258     0.612

  Females           4               10842               160      98.49   \<0.001   294.22    123.97        464.48                                              

  Area              Urban           4                   29124    479     99.25     \<0.001   141.74        50.67                232.81               0.023     0.88

  Rural             1               6796                34       \-      \-        50.03     33.26         66.80                                               

  Study time        2009-2012       3                   14370    1190    99.22     \<0.001   1149.51       532.33               1766.69              8.651     0.003

  2013-2014         4               34533               575      99.58   \<0.001   188.30    87.97         288.63                                              

  Study site        East of China   8                   46187    1586    99.46     \<0.001   494.32        362.42               626.23               0.286     0.593

  Central China     3               21134               617      99.45   \<0.001   290.11    47.37         532.84                                              

  Screening tools   CABS            5                   35580    1396    99.63     \<0.001   422.06        219.60               624.51               0.524     0.769

  CAST              1               701                 35       \-      0.012     499.29    338.06        660.52                                              

  CHAT              5               31040               772      99.33   \<0.001   431.86    268.90        594.83                                              

  Age (years)       \<=4            5                   29158    1536    99.37     \<0.001   530           260                  1040                 10.653    0.001

  \>4               3               22428               192      96.93   \<0.001   80        30            190                                                 

                                                                                                                                                               

  **Autism**        22              223189              4467     99.60   \<0.001   252.84    216.10        289.57               5245.70                        

  Gender            Males           12                  53265    2156    99.28     \<0.001   377.25        264.79               354.82               0.924     0.336

  Females           12              46841               1120     98.53   \<0.001   247.89    188.23        307.54                                              

  Study time        1996-2006       6                   42116    177     99.81     \<0.001   39.17         11                   71                   19.013    \<0.001

  2007-2014         9               70378               1503     99.91   \<0.001   349.82    216.66        482.98                                              

  Study site        East of China   14                  177279   3436    99.73     \<0.001   260.11        213.92               306.29               2.241     0.524

  West of China     4               23942               262      97.49   \<0.001   149.78    92.40         207.16                                              

  Central China     3               21968               769      98.4    \<0.001   334.73    151.68        517.78                                              

  Screening tools   ABC             4                   46116    684     98.86     \<0.001   136.67        44.47                228.87               0.791     0.673

  CABS              14              138768              3136     99.65   \<0.001   268.94    213.49        324.39                                              

  CHAT              4               38305               647      99.46   \<0.001   406.73    115.76        697.70                                              

  Age (years)       ≤3.58           5                   23170    794     98.77     \<0.001   290           140                  590                  0.567     0.451

  \>3.58            4               51439               3018     99.54   \<0.001   440       200           950                                                 
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

Screen tools: ABC, Autism Behavior Checklist; CABS, Clancy Autism Behavior Scale; CARS, Childhood Autism Rating Scale; CHAT, Checklist for Autism in Toddlers; CAST, Children Autism Spectrum Test
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